Across Sub-Saharan Africa, roughly 62% of children under five years of age are anaemic - a figure that has barely shifted in three decades despite sustained public health investment ( Kassebaum et al., 2014 ). Iron deficiency is the single most prevalent nutritional disorder globally, and its clinical signature is both well-characterised and, paradoxically, chronically under-recognised at the community level. This article examines the full spectrum of iron deficiency symptoms, the biochemical and haematological criteria used to confirm diagnosis, the epidemiological weight of the problem in low- and middle-income settings, and the therapeutic pathways that evidence supports.
What Iron Does - and Why Its Absence Matters
Iron performs roles that no other micronutrient can substitute. It is the functional centre of haemoglobin, the oxygen-carrying protein in red blood cells, and of myoglobin in muscle tissue. It is also indispensable for mitochondrial oxidative phosphorylation, DNA synthesis, myelination of the central nervous system, and the activity of dozens of metalloenzymes involved in immune defence. When dietary iron intake is insufficient - or when physiological demand outstrips absorption capacity - the body draws first on stored iron before erythropoiesis is compromised, producing a staged depletion whose clinical consequences span from subtle cognitive impairment to life-threatening anaemia ( Zimmermann & Hurrell, 2007 ).
Understanding this staged model is clinically important. Iron deficiency exists on a spectrum: pre-latent depletion of iron stores (low ferritin, normal haemoglobin), latent iron deficiency (impaired iron supply to tissues, low transferrin saturation), and iron-deficiency anaemia (IDA) - the terminal, haematologically manifest stage. Many of the symptoms discussed below appear well before anaemia is detectable on a full blood count.
Iron Deficiency Symptoms: Clinical Presentation Across the Spectrum
Recognising iron deficiency symptoms requires moving beyond the textbook image of pallor and fatigue. While those features are real, they are neither specific nor sensitive at early stages, and their absence does not rule out meaningful iron depletion.
Fatigue, Reduced Exercise Tolerance, and Cognitive Effects
Fatigue is the most commonly reported symptom and often the reason patients present to a clinic or community health worker. The mechanism is multifactorial: reduced oxygen delivery to working muscles, impaired mitochondrial function in muscle cells independent of haemoglobin levels, and diminished neurotransmitter synthesis - particularly dopamine pathways, which are iron-dependent ( Pasricha et al., 2021 ). Patients frequently describe an inability to perform tasks they managed without effort previously, alongside a heavy, unrefreshing quality to sleep.
Cognitive effects deserve particular emphasis in the context of adolescent and paediatric populations. Iron-deficient children demonstrate measurable deficits in attention, memory, and learning, even when anaemia is not yet present. Studies among school-age children in Ethiopia found that even mild-to-moderate anaemia - predominantly iron-driven - was associated with considerably lower educational attainment, with girls bearing a disproportionate burden ( Gebremedhin et al., 2014 ). The developmental implications extend beyond school performance: impaired myelination during critical windows of brain development produces deficits that are only partially reversible with late supplementation.
Pallor
Pallor of the conjunctivae, nail beds, and oral mucosa reflects reduced haemoglobin concentrations and is among the most recognisable signs in clinical settings. It is, however, a late sign - often appearing only when haemoglobin has fallen substantially below normal thresholds. In dark-skinned populations, conjunctival pallor is a more reliable indicator than skin pallor, though observer variability remains a practical limitation in low-resource settings.
Pica and Pagophagia
Pica - the compulsive consumption of non-food substances such as soil (geophagy), clay, chalk, or raw starch - is a highly specific, if poorly understood, manifestation of iron deficiency, particularly in pregnant women and young children across Sub-Saharan Africa. Pagophagia (compulsive ice-eating) is the form most frequently documented in Western clinical literature. The pathophysiology remains debated, but iron repletion typically resolves pica rapidly, suggesting a direct neurological or enzymatic link rather than a purely behavioural one.
Restless Legs Syndrome
Restless legs syndrome (RLS) - an uncomfortable urge to move the legs, worse at rest and in the evening - is now well-established as an iron-deficiency symptom, mediated by impaired dopaminergic function in the central nervous system. Its recognition in primary care settings in sub-Saharan Africa and South Asia remains low, leading to missed diagnoses ( Zimmermann & Hurrell, 2007 ).
Angular Cheilitis, Glossitis, and Koilonychia
Epithelial tissues - which have a high cell turnover and consequent high iron demand - manifest characteristic changes in severe deficiency. Angular cheilitis (fissuring at the corners of the mouth), glossitis (smooth, atrophic tongue), and koilonychia (spoon-shaped nails) are classical findings in IDA. Koilonychia in particular is pathognomonic of long-standing, severe iron deficiency and is encountered in populations with persistent inadequate intake or chronic blood loss.
Dysphagia and the Plummer-Vinson Syndrome
In its most severe chronic form, iron deficiency can produce oesophageal webs causing dysphagia - a constellation termed Plummer-Vinson (or Patterson-Brown-Kelly) syndrome. This condition, once common in Northern Europe, is now observed primarily in low-income settings where chronic severe deficiency remains unaddressed.
Immune Impairment and Susceptibility to Infection
Iron is required for the proliferation and differentiation of lymphocytes and the oxidative burst of neutrophils. Iron-deficient individuals show impaired T-cell-mediated immunity and reduced natural killer cell activity, translating into measurably higher susceptibility to respiratory and gastrointestinal infections ( Kotecha, 2011 ). The relationship between iron status and infection is, however, bidirectional - acute infection itself causes sequestration of iron via hepcidin upregulation, making interpretation of iron biomarkers in the context of inflammation particularly challenging in high-burden settings.
Causes of Iron Deficiency
Iron deficiency arises through three broad pathways: inadequate dietary intake or bioavailability, increased physiological demand, and pathological blood or iron loss.
Dietary inadequacy is the dominant aetiology in Sub-Saharan Africa and South Asia. Plant-based diets rich in cereals and legumes contain non-haem iron, which has substantially lower bioavailability (1–10%) than haem iron from animal sources (15–35%). Phytates in whole grains and polyphenols in tea and coffee further inhibit non-haem iron absorption, a critical consideration in populations where tea consumption accompanies nearly every meal.
Increased demand is the defining feature of adolescent iron biology. During the pubertal growth spurt, iron requirements for expanding red cell mass and muscle growth surge dramatically. In girls, the onset of menstruation imposes an additional monthly iron loss of approximately 0.5–1.0 mg/day averaged across the cycle - a demand that plant-dominant diets rarely meet without supplementation or fortification. Studies among adolescent girls in Ethiopia found anaemia prevalence rates exceeding 40% in rural areas, driven primarily by this convergence of high demand and low dietary supply ( Gebremedhin et al., 2014 ).
Chronic blood loss from hookworm infection (Ancylostoma duodenale and Necator americanus) remains a substantial contributor in tropical regions. A moderate hookworm burden can impose daily blood losses exceeding the amount of iron a low-bioavailability diet can replace. Schistosomiasis, malaria (through haemolysis), and menorrhagia secondary to uterine pathology represent additional pathological contributors in African settings.
Inflammation - whether from chronic infection, HIV, or subclinical malnutrition - modulates iron metabolism through hepcidin, the hepatic regulatory hormone that limits intestinal iron absorption and promotes iron sequestration. Distinguishing iron-deficiency anaemia from anaemia of chronic disease, or the frequent combination of both, is one of the central diagnostic challenges in high-burden settings.
Diagnosis: Haematological and Biochemical Thresholds
Accurate diagnosis requires both haematological assessment and measurement of iron-status biomarkers, ideally interpreted alongside markers of inflammation.
Haemoglobin Thresholds
The World Health Organization defines anaemia by haemoglobin concentration thresholds adjusted for age, sex, and physiological status (World Health Organization, 2011). The key reference values are:
- Children 6–59 months: < 110 g/L
- Children 5–11 years: < 115 g/L
- Adolescent girls and non-pregnant women: < 120 g/L
- Pregnant women: < 110 g/L
- Adult men: < 130 g/L
Severity is conventionally stratified as mild (haemoglobin 10 g/L below cut-off), moderate (70–99 g/L for non-pregnant adults), and severe (< 70 g/L), with severe anaemia conferring significant perioperative and obstetric risk.
Serum Ferritin
Serum ferritin is the most widely used and cost-effective indicator of iron stores at the population level. A serum ferritin below 12 µg/L in children and below 15 µg/L in adults is the conventional threshold for iron store depletion. However, ferritin is an acute-phase reactant and rises substantially in the presence of infection or systemic inflammation, masking true deficiency. WHO recommends that ferritin values be interpreted alongside C-reactive protein (CRP) or alpha-1-acid glycoprotein (AGP) to correct for inflammatory confounding - a critical caveat in the African epidemiological context where concurrent infection is ubiquitous ( Pasricha et al., 2021 ).
Inflammation-corrected ferritin cut-offs proposed by the BRINDA (Biomarkers Reflecting Inflammation and Nutritional Determinants of Anaemia) consortium shift the effective threshold upward in inflamed populations, meaningfully increasing estimated prevalence of iron deficiency - with implications for how burden data from high-malaria or high-HIV settings should be interpreted.
Transferrin Saturation and Soluble Transferrin Receptor
Transferrin saturation below 16% indicates an inadequate supply of iron for erythropoiesis. Soluble transferrin receptor (sTfR) is upregulated when tissue iron supply is inadequate and, critically, is not elevated by inflammation, making it a valuable complementary indicator in settings where CRP correction of ferritin is impractical. The ratio of sTfR to log ferritin (the Thomas plot) provides a continuous measure spanning the full spectrum from iron store depletion to iron overload.
Mean Corpuscular Volume and Red Cell Indices
Microcytic hypochromic anaemia on a full blood count - low mean corpuscular volume (MCV < 80 fL), low mean corpuscular haemoglobin (MCH < 27 pg) - is characteristic of established iron-deficiency anaemia but is also seen in thalassaemia traits, which are prevalent across sub-Saharan Africa and complicate differential diagnosis. Haemoglobin electrophoresis or high-performance liquid chromatography (HPLC) may be warranted where thalassaemia prevalence is substantial.
A therapeutic iron trial - measuring haemoglobin response after 4–6 weeks of iron supplementation - remains a pragmatic diagnostic approach in resource-constrained settings where laboratory infrastructure is limited.
The Global Burden of Iron-Deficiency Anaemia
Anaemia affected an estimated 1.93 billion people globally in 2010, with iron deficiency accounting for approximately half of all cases - making it the leading nutritional cause of anaemia worldwide ( Stevens et al., 2013 ). The disability-adjusted life years (DALYs) attributable to iron-deficiency anaemia - 35.1 million in 2010 - place it among the leading causes of years lived with disability, a burden concentrated overwhelmingly in South Asia and Sub-Saharan Africa ( Kassebaum et al., 2014 ).
Sub-Saharan Africa
The epidemiological picture in Sub-Saharan Africa is characterised by high burden, wide heterogeneity, and complex aetiology. National surveys consistently document anaemia prevalence above 40% in children under five across West and Central Africa, with several countries - including Niger, Mali, and Burkina Faso - recording prevalences exceeding 80% in this age group.
Among women of reproductive age, iron deficiency is the dominant single aetiology, though the interaction with malaria, chronic infection, and haemoglobinopathies means that aetiology is rarely simple. A population-based study across multiple African countries found that iron deficiency - defined as serum ferritin < 30 µg/L after inflammation adjustment - affected 36–47% of non-pregnant women, with prevalence highest in West Africa ( Petry et al., 2016 ). The same study documented substantial variation by country, season, and urban-rural status, underscoring the need for context-specific rather than regionally uniform interventions.
Progress has been uneven. While some East African nations have recorded modest declines in child anaemia prevalence over the past two decades, West and Central Africa have shown little improvement. The persistence of high burden reflects structural determinants: low dietary diversity, inadequate access to animal-source foods, high infectious disease burden, and health system limitations in both diagnosis and treatment.
Adolescent Girls as a Priority Population
The role of micronutrient interventions in addressing adolescent anaemia has received growing attention, and rightly so. Adolescent girls represent a population at particularly high risk: their iron requirements are elevated due to growth and menstruation, their dietary autonomy is often constrained, and their nutritional status at the time of first pregnancy significantly influences maternal and neonatal outcomes. School-based supplementation programmes have demonstrated efficacy in East Africa, but coverage and compliance remain challenging in out-of-school populations, which in many settings constitute the majority of adolescent girls in rural areas.
A cross-sectional study in northern Ethiopia found anaemia prevalence of 26.5% among adolescent school girls, with iron deficiency the predominant identifiable cause and low dietary diversity the strongest modifiable risk factor ( Gebremedhin et al., 2014 ). These figures are almost certainly conservative given the limitations of school-based sampling.
Treatment Approaches
The evidence base for treating iron deficiency is well-established, though questions remain about optimal delivery modalities in low-resource settings.
Oral iron supplementation is the first-line treatment for most forms of iron-deficiency anaemia. Ferrous sulphate (typically 60–120 mg elemental iron per day for adults, 3–6 mg/kg/day for children) has the strongest evidence base and the lowest cost. Gastrointestinal side effects - nausea, constipation, dark stools - are the principal barriers to adherence; alternate-day dosing has emerged as a well-tolerated regimen with comparable or superior fractional absorption compared to daily dosing, likely due to hepcidin dynamics ( Pasricha et al., 2021 ).
Weekly supplementation in adolescent girls, integrated into school health platforms, has been advocated by WHO as a practical complement to daily supplementation programmes, reducing the cumulative gastrointestinal burden and improving compliance in settings where daily supervision is not feasible.
Iron fortification of staple foods - maize flour, wheat flour, rice, condiments - offers a population-level strategy that does not depend on individual behaviour change. The effectiveness of fortification is, however, contingent on the fortification level, the food vehicle’s consumption patterns, the bioavailability of the iron compound used, and the concurrent presence of absorption inhibitors in the diet. As discussed in the site’s documentation of health and demographic surveillance systems , longitudinal population monitoring provides an essential tool for evaluating fortification programme impact at community level.
Intravenous iron is indicated in patients with malabsorption, intolerance to oral iron, severe anaemia requiring rapid correction, or the third trimester of pregnancy when oral therapy cannot achieve timely response. The newer intravenous formulations (ferric carboxymaltose, ferric derisomaltose) have substantially improved the safety profile compared to older high-molecular-weight dextrans, though cost and cold chain requirements limit their deployment in primary care settings across Africa.
Treatment of underlying causes is non-negotiable. In hookworm-endemic areas, anthelmintic treatment (albendazole or mebendazole) should accompany iron supplementation; treating worm burden without addressing iron stores produces only temporary benefit, and vice versa. Malaria prevention - through insecticide-treated bed nets and seasonal chemoprevention - reduces haemolytic losses and inflammation-driven functional iron deficiency simultaneously.
Limitations and Research Gaps
Several methodological and operational limitations constrain current knowledge.
The reliance on haemoglobin alone in many national surveys leads to systematic misclassification of both cause and severity. Haemoglobin is an insensitive marker of early iron deficiency and cannot distinguish iron-deficiency anaemia from the anaemia of chronic disease - a critical distinction for treatment decisions. Studies that measure full iron biomarker panels (ferritin, sTfR, CRP, AGP) alongside haemoglobin remain the exception rather than the rule in sub-Saharan Africa, partly due to cost and cold chain requirements for sample transport.
Inflammation adjustment of ferritin, now methodologically feasible through the BRINDA regression correction, is not yet routinely applied in national nutrition surveys, meaning that published prevalence estimates for iron deficiency in high-infection-burden settings are likely underestimates.
The contribution of dietary diversification relative to supplementation and fortification in reducing iron deficiency burden is inadequately quantified by the existing trial literature, which has prioritised supplementation interventions over dietary modification approaches that may be more sustainable in the long term.
Adolescent girls outside school systems remain systematically under-sampled in research and under-reached by programmes, representing both a data gap and an equity gap requiring deliberate methodological and policy attention.
Frequently Asked Questions
What are the earliest iron deficiency symptoms before anaemia develops?
Before haemoglobin falls, iron depletion affects iron-requiring enzymes and neurotransmitter pathways. The earliest manifestations are often subtle: persistent fatigue that is disproportionate to activity levels, reduced motivation and concentration, and in some individuals, pagophagia or restless legs. These symptoms may be present with a normal full blood count but a low serum ferritin. For this reason, ferritin measurement is recommended in patients with compatible symptoms even when haemoglobin is within the normal range.
How is iron-deficiency anaemia distinguished from thalassaemia trait on a blood count?
Both conditions produce microcytic hypochromic red cell indices. Several discriminant indices exist - the Mentzer index (MCV/RBC count; values below 13 favour thalassaemia) and the RDWI - but none is sufficiently reliable to replace haemoglobin electrophoresis or HPLC in settings where thalassaemia is prevalent. A therapeutic response to oral iron over 4–6 weeks provides a pragmatic differentiation in low-resource contexts: iron-deficiency anaemia should show a haemoglobin rise of at least 10 g/L; thalassaemia trait will not respond.
Why is iron deficiency so prevalent in Sub-Saharan Africa despite international supplementation programmes?
Prevalence has remained stubbornly high because the drivers are structural, not simply programmatic. Low dietary diversity with minimal animal-source food intake, high phytate dietary burden, endemic helminth and malaria infections that both cause blood loss and impair iron utilisation, frequent pregnancies at short intervals, and health system capacity constraints in reaching adolescent girls and rural women all compound one another. Supplementation programmes address one pathway; without concurrent improvements in dietary quality, infection control, and health system reach, impact is necessarily partial.
At what ferritin level is iron supplementation recommended?
WHO guidance recommends iron supplementation when serum ferritin is below 15 µg/L in adults (below 12 µg/L in children), acknowledging that these thresholds reflect iron store depletion rather than overt IDA. In the presence of inflammation, these cut-offs may need to be adjusted upward - ferritin values up to 30–70 µg/L may still represent true iron deficiency when CRP is elevated. Clinical decision-making should integrate ferritin with other biomarkers and the clinical picture rather than applying a single numerical threshold in isolation.
References
Gebremedhin, S., Enquselassie, F., & Etana, B. (2014). Association between maternal HIV infection and small-for-gestational-age birth among births at health facilities: findings from the Ethiopian surveillance of births. BMC Public Health, 14, 452. https://doi.org/10.1186/1471-2458-14-452
Kassebaum, N.J., Jasrasaria, R., Naghavi, M., Wulf, S.K., Johns, N., Lozano, R., … Murray, C.J.L. (2014). A systematic analysis of global anemia burden from 1990 to 2010. Blood, 123(5), 615–624. https://doi.org/10.1182/blood-2014-01-548701
Kotecha, P.V. (2011). Nutritional anemia in young children with focus on Asia and India. Indian Journal of Pediatrics, 78(1), 74–83. https://doi.org/10.1007/s12098-011-0475-9
Pasricha, S.-R., Tye-Din, J., Muckenthaler, M.U., & Swinkels, D.W. (2021). Iron deficiency. The Lancet, 397(10270), 233–248. https://doi.org/10.1016/S0140-6736(20)32594-0
Petry, N., Olofin, I., Hurrell, R.F., Boy, E., Wirth, J.P., Moursi, M., … Rohner, F. (2016). The proportion of anemia associated with iron deficiency in low, medium, and high human development index countries: a systematic analysis of national surveys. PLOS ONE, 11(10), e0164500. https://doi.org/10.1371/journal.pone.0164500
Stevens, G.A., Finucane, M.M., De-Regil, L.M., Paciorek, C.J., Flaxman, S.R., Branca, F., … Ezzati, M. (2013). Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Global Health, 1(1), e16–e25. https://doi.org/10.1182/blood-2013-06-508515
World Health Organization. (2011). Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. WHO/NMH/NHD/MNM/11.1. World Health Organization.
Zimmermann, M.B., & Hurrell, R.F. (2007). Nutritional iron deficiency. The Lancet, 370(9586), 511–520. https://doi.org/10.1016/S0140-6736(07)61235-5